Mesenchymal Stem Cell Isolation from Human Umbilical Cord Tissue: Understanding and Minimizing Variability in Cell Yield for Process Optimization.

Human tissue banks are a potential source of cellular material for the nascent cell-based therapy industry; umbilical cord (UC) tissue is increasingly privately banked in such facilities as a source of mesenchymal stem cells for future therapeutic use. However, early handling of UC tissue is relativ...

Descripción completa

Detalles Bibliográficos
Publicado en:Biopreservation & Biobanking Vol. 11; no. 5; pp. 291 - 299
Autores principales: Iftimia-Mander, Andreea, Hourd, Paul, Dainty, Roger, Thomas, Robert J.
Formato: Journal Article
Publicado: Mary Ann Liebert, Inc. Oct2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=91255177&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 91255177
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        19475535
        AXZA
      jtl: Biopreservation & Biobanking
      issn: 19475535
      maglogo: N
    pubinfo:
      dt: Oct2013
      vid: 11
      iid: 5
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        91255177
        10.1089/bio.2013.0027
        91255177
      ppf: 291
      ppct: 8
      formats:
      tig:
        atl: Mesenchymal Stem Cell Isolation from Human Umbilical Cord Tissue: Understanding and Minimizing Variability in Cell Yield for Process Optimization.
      aug:
        au:
          Iftimia-Mander, Andreea
          Hourd, Paul
          Dainty, Roger
          Thomas, Robert J.
        affil: Centre for Biological Engineering, Healthcare Research Group, Wolfson School of Mechanical and Manufacturing Engineering, Loughborough University, Leicestershire, United Kingdom.
      sug:
      ab: Human tissue banks are a potential source of cellular material for the nascent cell-based therapy industry; umbilical cord (UC) tissue is increasingly privately banked in such facilities as a source of mesenchymal stem cells for future therapeutic use. However, early handling of UC tissue is relatively uncontrolled due to the clinical demands of the birth environment and subsequent transport logistics. It is therefore necessary to develop extraction methods that are robust to real-world operating conditions, rather than idealized operation. Cell yield, growth, and differentiation potential of UC tissue extracted cells was analyzed from tissue processed by explant and enzymatic digestion. Variability of cell yield extracted with the digestion method was significantly greater than with the explant method. This was primarily due to location within the cord tissue (higher yield from placental end) and time delay before tissue processing (substantially reduced yield with time). In contrast, extraction of cells by explant culture was more robust to these processing variables. All cells isolated showed comparable proliferative and differentiation functionality. In conclusion, given the challenge of tightly controlled operating conditions associated with isolation and shipping of UC tissue to banking facilities, explant extraction of cells offers a more robust and lower-variability extraction method than enzymatic digestion.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N